EPISODE · Aug 29, 2022 · 16 MIN
Starting Strong at First Relapse in Multiple Myeloma: Insights to Guide Treatment Selection in Lenalidomide-Refractory Patients
from PeerVoice Clinical Pharmacology Video · host PeerVoice
Starting Strong at First Relapse in Multiple Myeloma: Insights to Guide Treatment Selection in Lenalidomide-Refractory Patients
Embed this episode
What this episode covers
Visit https://www.peervoice.com/WZK860 to view the entire programme with slides. After completing “Starting Strong at First Relapse in Multiple Myeloma: Insights to Guide Treatment Selection in Lenalidomide-Refractory Patients”, participants will be able to: Discuss evolving treatment goals in lenalidomide-refractory patients with multiple myeloma (MM) at first relapse; Outline key efficacy and safety data with new regimens for relapsed/refractory MMOutline key efficacy and safety data with new regimens for relapsed/refractory MM; and Formulate evidence-based management strategies for patients with MM experiencing relapse, based on key patient and disease factors.
Ready to play
Starting Strong at First Relapse in Multiple Myeloma: Insights to Guide Treatment Selection in Lenalidomide-Refractory Patients
No transcript for this episode yet
Similar Episodes
No similar episodes found.